StockData
ENDRA Life Sciences Inc. logo

ENDRA Life Sciences Inc. (NDRA) company profile

NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$4.04+0.12 (+2.93%)

Close on Nov 18, 2026Market cap $6.05MP/E –Yield –

About ENDRA Life Sciences

Electromedical & Electrotherapeutic Apparatus, SIC 3845

ENDRA Life Sciences Inc. is a medical technology company developing Thermo-Acoustic Enhanced Ultrasound (TAEUS), a non-invasive platform designed to evaluate tissue composition and assess liver fat at the point of care. The company focuses primarily on liver applications to detect and monitor metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH). Its initial liver product operates alongside conventional ultrasound systems to measure liver fat without requiring large capital equipment investments. The company targets pharmaceutical firms and clinical research organizations conducting metabolic trials, concierge primary care networks, bariatric and metabolic clinics, and broader primary and internal medicine practices.

The company is headquartered in Ann Arbor, Michigan, and conducts business in the United States and the European Union, where its MASLD application holds CE mark certification. In addition, ENDRA maintains a Digital Asset Treasury initiative investing in decentralized finance assets and uses third-party component suppliers and contract manufacturers to produce its TAEUS systems.

Summary of the business section of ENDRA Life Sciences's latest annual report, written by StockData.

Company profile

Company

Legal name
ENDRA Life Sciences Inc.
Founded
2007
Headquarters
Ann Arbor, MI
Address
3600 Green Court, Suite 350 48105
Phone
(734) 335-0468
Employees
11, Dec 31, 2025
Industry
Electromedical & Electrotherapeutic Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
RBSM LLP, Houston, Texas

Stock & identifiers

Ticker
NDRA
Exchange
Nasdaq
IPO date
Jun 30, 2017
Shares outstanding
1M, Aug 14, 2026
Public float
$2.69M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-35 reverse, Nov 7, 2024; 1-for-50 reverse, Aug 20, 2024; 1-for-20 reverse, Dec 9, 2022
SEC CIK
1681682
CUSIP
29273B401
ISIN
US29273B4014
FIGI
BBG00FD4RCV3
Share class FIGI
BBG00FD4RDM1
LEI
6488380RAKK4NN716I68
EIN
26-0579295

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Alexander Y. TokmanChief Executive Officer, Director101,926
Richard JacrouxChief Financial Officer33,461
Anthony DigiandomenicoDirector136,589
Michael HarshDirector65,710
Lou BaseneseDirector65,709

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2024$215.19K$194.78K$148.09K$30–
FY2023$0$0$373.35K$15320–
FY2022$0$0$430.87K$29420–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2024

Summary compensation table from the latest proxy statement

ExecutiveSalaryOption awardsOtherTotalvs. prior year
Alexander Tokman
Chief Executive Officer (since August 13, 2024)
$114.23K$954$100.00K$215.19K–
Francois Michelon
Former Chief Executive Officer (until August 12, 2024)
$202.13K–$112.52K$314.65K-51%
Michael Thornton
Chief Technology Officer
$221.69K–$392$222.08K-58%
Richard Jacroux
Chief Financial Officer (since August 8, 2024)
$95.90K––$95.90K–
Irina Pestrikova
Former Senior Director, Finance (until August 8, 2024)
$126.30K––$126.30K-41%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 11 employees,”

Corporate history

Events identified from SEC filings

See a number that looks wrong?